The Role of TSC1 in the Macrophages Against Vibrio vulnificus Infection

Xian-Hui Huang1,2,3, Yao Ma1,2,4, Han Lou5

  • 1Department of Microbiology and Immunology, School of Laboratory Medicine and Life Science, Wenzhou Medical University, Wenzhou, China.

Insights

Tuberous sclerosis complex 1 (TSC1) is vital for macrophage response to Vibrio vulnificus (V. vulnificus) infection. Loss of TSC1 impairs bacterial clearance and survival, highlighting the TSC1-mTOR pathway

Area of Science:

  • Immunology
  • Microbiology
  • Cell Biology

Background:

  • Vibrio vulnificus (V. vulnificus) causes severe human infections.
  • Macrophages are key in fighting pathogens, but their role in V. vulnificus infection is unclear.
  • Tuberous sclerosis complex 1 (TSC1) is a protein complex involved in cell growth and metabolism.

Purpose of the Study:

  • To investigate the role of TSC1 in macrophage response to V. vulnificus infection.
  • To elucidate the mechanisms by which TSC1 regulates macrophage polarization, bacterial clearance, and cell death.
  • To determine the involvement of the TSC1-mammalian target of rapamycin (mTOR) signaling pathway.

Main Methods:

  • Utilized mouse models with myeloid-specific deletion of TSC1.
  • Performed in vivo and in vitro experiments to assess bacterial clearance.
  • Analyzed macrophage polarization (M1/M2) and cell death.
  • Investigated the effect of mTOR inhibition on macrophage responses.

Main Results:

  • Myeloid-specific deletion of TSC1 reduced survival in mice infected with V. vulnificus.
  • TSC1 deficiency led to enhanced M1 macrophage polarization but impaired bacterial clearance.
  • Inhibition of mTOR reversed V. vulnificus-induced hypersensitive M1 response and improved bactericidal activity.
  • Macrophage cell death during infection was dependent on mTORC1 signaling.

Conclusions:

  • TSC1 is critical for regulating macrophage polarization and bacterial clearance against V. vulnificus.
  • The TSC1-mTOR signaling pathway plays a crucial role in innate immunity against V. vulnificus.
  • Targeting the TSC1-mTOR pathway may offer therapeutic strategies for V. vulnificus infections.